Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Response to "Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later".

van Esch HJ, Geijteman ECT, van der Rijt CCD.

J Pain Symptom Manage. 2019 Apr;57(4):e1-e2. doi: 10.1016/j.jpainsymman.2019.01.004. Epub 2019 Jan 17. No abstract available.

PMID:
30660674
2.

Correction: Palliative care team consultation and quality of death and dying in a university hospital: A secondary analysis of a prospective study.

Brinkman-Stoppelenburg A, Witkamp FE, van Zuylen L, van der Rijt CCD, van der Heide A.

PLoS One. 2018 Nov 29;13(11):e0208564. doi: 10.1371/journal.pone.0208564. eCollection 2018.

3.

Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or Bioradiotherapy.

Kuip EJM, Oldenmenger WH, Oomen-de Hoop E, Verduijn GM, Thijs-Visser MF, de Bruijn P, van Meerten E, Koolen SLW, Mathijssen RHJ, van der Rijt CCD.

Cancers (Basel). 2018 Nov 15;10(11). pii: E445. doi: 10.3390/cancers10110445.

4.

Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients.

Bechakra M, Moerdijk F, van Rosmalen J, Koch BCP, van der Rijt CCD, Sillevis Smitt PAE, Jongen JLM.

Eur J Cancer. 2018 Dec;105:79-87. doi: 10.1016/j.ejca.2018.09.036. Epub 2018 Nov 12.

PMID:
30439627
5.

Scopolaminebutyl given prophylactically for death rattle: study protocol of a randomized double-blind placebo-controlled trial in a frail patient population (the SILENCE study).

van Esch HJ, van Zuylen L, Oomen-de Hoop E, van der Heide A, van der Rijt CCD.

BMC Palliat Care. 2018 Sep 7;17(1):105. doi: 10.1186/s12904-018-0359-4.

6.

Palliative care team consultation and quality of death and dying in a university hospital: A secondary analysis of a prospective study.

Brinkman-Stoppelenburg A, Witkamp FE, van Zuylen L, van der Rijt CCD, van der Heide A.

PLoS One. 2018 Aug 23;13(8):e0201191. doi: 10.1371/journal.pone.0201191. eCollection 2018. Erratum in: PLoS One. 2018 Nov 29;13(11):e0208564.

7.

Effects of smoking and body mass index on the exposure of fentanyl in patients with cancer.

Kuip EJM, Oldenmenger WH, Thijs-Visser MF, de Bruijn P, Oosten AW, Oomen-de Hoop E, Koolen SLW, Van der Rijt CCD, Mathijssen RHJ.

PLoS One. 2018 Jun 8;13(6):e0198289. doi: 10.1371/journal.pone.0198289. eCollection 2018.

8.

Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl.

Kuip EJM, Oldenmenger WH, Visser-Thijs MF, de Bruijn P, Oomen-de Hoop E, Mathijssen RHJ, Van der Rijt CCD, Koolen SW.

Oncotarget. 2018 Apr 6;9(26):18269-18276. doi: 10.18632/oncotarget.24812. eCollection 2018 Apr 6.

9.

Medication Discontinuation at the End of Life: A Questionnaire Study on Physicians' Experiences and Opinions.

Geijteman ECT, Huisman BAA, Dees MK, Perez RSGM, van der Rijt CCD, van Zuylen L, van der Heide A.

J Palliat Med. 2018 Aug;21(8):1166-1170. doi: 10.1089/jpm.2017.0501. Epub 2018 Apr 18.

PMID:
29668346
10.

Interventions in hospitalised patients with cancer: the importance of impending death awareness.

Geijteman ECT, Graaf MV, Witkamp FE, Norden SV, Stricker BH, van der Rijt CCD, van der Heide A, van Zuylen L.

BMJ Support Palliat Care. 2018 Sep;8(3):278-281. doi: 10.1136/bmjspcare-2017-001466. Epub 2018 Feb 9.

PMID:
29440148
11.

Feasibility and validity of a tool for identification of people with intellectual disabilities in need of palliative care (PALLI).

Vrijmoeth C, Groot CM, Christians MGM, Assendelft WJJ, Festen DAM, van der Rijt CCD, van Schrojenstein Lantman-de Valk HMJ, Vissers KCP, Echteld MA.

Res Dev Disabil. 2018 Jan;72:67-78. doi: 10.1016/j.ridd.2017.10.020. Epub 2017 Nov 5.

PMID:
29107852
12.

Development and feasibility of a web application to monitor patients' cancer-related pain.

Oldenmenger WH, Baan MAG, van der Rijt CCD.

Support Care Cancer. 2018 Feb;26(2):635-642. doi: 10.1007/s00520-017-3877-3. Epub 2017 Sep 19.

13.

Identifying the subtypes of cancer-related fatigue: results from the population-based PROFILES registry.

Thong MSY, Mols F, van de Poll-Franse LV, Sprangers MAG, van der Rijt CCD, Barsevick AM, Knoop H, Husson O.

J Cancer Surviv. 2018 Feb;12(1):38-46. doi: 10.1007/s11764-017-0641-0. Epub 2017 Sep 9.

PMID:
28889367
14.

Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.

Aarts MJ, Vriens BE, de Boer M, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Tol J, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, van der Rijt CCD, Smilde TJ, van der Velden AW, Peer N, Tjan-Heijnen VCG.

Oncology. 2017;93(5):323-328. doi: 10.1159/000479067. Epub 2017 Aug 22.

PMID:
28848182
15.

Is there a role for pharmacogenetics in the dosing of fentanyl?

Koolen SL, Van der Rijt CC.

Pharmacogenomics. 2017 Apr;18(5):417-419. doi: 10.2217/pgs-2017-0022. Epub 2017 Mar 27. No abstract available.

16.

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.

Oosten AW, Abrantes JA, J├Ânsson S, Matic M, van Schaik RHN, de Bruijn P, van der Rijt CCD, Mathijssen RHJ.

Clin Pharmacokinet. 2017 Jul;56(7):733-746. doi: 10.1007/s40262-016-0471-7.

17.

A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients.

Kuip EJ, Zandvliet ML, Koolen SL, Mathijssen RH, van der Rijt CC.

Br J Clin Pharmacol. 2017 Feb;83(2):294-313. doi: 10.1111/bcp.13129. Epub 2016 Oct 29. Review.

18.

Adherence to Analgesics in Oncology Outpatients: Focus on Taking Analgesics on Time.

Oldenmenger WH, Sillevis Smitt PAE, de Raaf PJ, van der Rijt CCD.

Pain Pract. 2017 Jun;17(5):616-624. doi: 10.1111/papr.12490. Epub 2016 Oct 14.

PMID:
27739244
19.

Physician-Reported Symptoms and Interventions in People with Intellectual Disabilities Approaching End of Life.

Vrijmoeth C, Christians MG, Festen DA, Groot M, van der Heide A, van der Rijt CC, Tonino M, Echteld MA.

J Palliat Med. 2016 Nov;19(11):1142-1147. Epub 2016 Sep 1.

PMID:
27585357
20.

Feasibility of assessing patients' acceptable pain in a randomized controlled trial on a patient pain education program.

Oldenmenger WH, van der Rijt CC.

Palliat Med. 2017 Jun;31(6):553-558. doi: 10.1177/0269216316664492. Epub 2016 Aug 9.

PMID:
27507634

Supplemental Content

Loading ...
Support Center